2019 has been a rotten year for Abiomed 's (NASDAQ: ABMD) investors. Shares of the temporary heart pump maker have fallen more than 40% since January in response to a slew of negative headlines. Meanwhile, Abiomed's revenue and net income have continued to grow . The combination has pulled...

Abiomed, Inc. (NASDAQ:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief Executive Officer, will present at the 31 st Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2019 at 3:00pm ...

Abiomed ( ABMD +4.8% ) is up on double normal volume after its medical office issued its review of two observational studies  presented at the American Heart Association Scientific Sessions that questioned the value proposition of its Impella heart pump. More news on: Abiomed, In...